Last reviewed · How we verify

NCT05541133

Effect of Acute Exercise on Exosome Associated Biomarkers

Completed Last updated 9 April 2025
What this trial tests

trial in Healthy in 12 participants. Completed in 31 December 2024.

Timeline
21 June 2022
Primary endpoint
9 July 2022
31 December 2024

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment12
Start date21 June 2022
Primary completion9 July 2022
Estimated completion31 December 2024
Sites1 location across United States

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 45, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study is being done to understand the underlying mechanism by which exercise affects the body on the cellular level, in an acute aerobic endurance setting. This may help to better understand the overall benefits of endurance exercise.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05541133.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing